Revenue - Reimbursement of R and D Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Research and Development Reimbursement
Total reduction to R and D expense	$ 6,682	$ 7,891	$ 10,078
Viatris
Research and Development Reimbursement
Total reduction to R and D expense	$ 6,682	2,072	1,524
Janssen
Research and Development Reimbursement
Total reduction to R and D expense		$ 5,819	$ 8,554